Cargando…

De-escalating chemotherapy for stage II colon cancer?

BACKGROUND: Although adjuvant chemotherapy is recommended for patients with stage II colon cancer characterized by poor prognostic features, its pros and cons remain a controversial issue. We aim to evaluate the real effectiveness of chemotherapy on stage II colon cancer as well as select suitable p...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fu, Jianfei, Wu, Lunpo, Ge, Chenyang, Xu, Tiantian, Li, Dan, Fu, Wei, Wang, Liangjing, Du, Jinlin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2019
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6710694/ https://www.ncbi.nlm.nih.gov/pubmed/31489031 http://dx.doi.org/10.1177/1756284819867553

Ejemplares similares

Early T Stage Is Associated With Poor Prognosis in Patients With Metastatic Liver Colorectal Cancer
por: Wu, Lunpo, et al.
Publicado: (2020)

Young Patients with Hormone Receptor-Positive Breast Cancer Have a Higher Long-Term Risk of Breast Cancer Specific Death
por: Fu, Jianfei, et al.
Publicado: (2019)

Young-onset breast cancer: a poor prognosis only exists in low-risk patients
por: Fu, Jianfei, et al.
Publicado: (2019)

Survival outcomes and surgical intervention of small intestinal neuroendocrine tumors: a population based retrospective study
por: Wu, Lunpo, et al.
Publicado: (2016)

Mucinous Histology Might Be an Indicator for Enhanced Survival Benefit of Chemotherapy in Stage II Colon Cancer
por: Huang, Yong, et al.
Publicado: (2020)

Serine Metabolism Regulates YAP Activity Through USP7 in Colon Cancer
por: Zhao, Xiaoya, et al.
Publicado: (2021)

De-escalating chemotherapy for stage I–II gastric neuroendocrine carcinoma? A real-world competing risk analysis
por: Du, Danwei, et al.
Publicado: (2023)

Adjuvant Chemotherapy for Stage II Colon Cancer
por: Rebuzzi, Sara Elena, et al.
Publicado: (2020)

The Impact of Delayed Chemotherapy on Its Completion and Survival Outcomes in Stage II Colon Cancer Patients
por: Xu, Fang, et al.
Publicado: (2014)

Clinical Nomogram for Predicting Survival Outcomes in Early Mucinous Breast Cancer
por: Fu, Jianfei, et al.
Publicado: (2016)

Adjuvant Chemotherapy Benefit in Elderly Stage II/III Colon Cancer Patients
por: Chen, Xin, et al.
Publicado: (2022)

Patient perspectives on chemotherapy de‐escalation in breast cancer
por: Rocque, Gabrielle B., et al.
Publicado: (2021)

Immunoscore(®) as a predictor of response to chemotherapy in stage II and stage III colon cancer
por: Mlecnik, Bernhard, et al.
Publicado: (2015)

Synchronous Resectable Metastatic Colorectal Cancer: Lymph Node Involvement Predicts Poor Outcome
por: Fu, Jianfei, et al.
Publicado: (2015)

Adjuvant chemotherapy for stage II colon cancer: who really needs it
por: Yang, Yan, et al.
Publicado: (2018)

Radiation dose escalation by simultaneous modulated accelerated radiotherapy combined with chemotherapy for esophageal cancer: a phase II study
por: Chen, Jianzhou, et al.
Publicado: (2016)

Dose-Escalated Robotic SBRT for Stage I–II Prostate Cancer
por: Meier, Robert
Publicado: (2015)

The impact of age on outcomes of breast cancer in different hormone receptor and HER2 groups
por: Zheng, Hongjuan, et al.
Publicado: (2023)

The Changing Role of Gene-Expression Profiling in the Era of De-escalating Adjuvant Chemotherapy in Early-Stage Breast Cancer
por: van Steenhoven, J. E. C., et al.
Publicado: (2019)

Duration of FOLFOX Adjuvant Chemotherapy in High-Risk Stage II and Stage III Colon Cancer With Deficient Mismatch Repair
por: Hu, Huabin, et al.
Publicado: (2020)

The Role of D-3-Phosphoglycerate Dehydrogenase in Cancer
por: Zhao, Xiaoya, et al.
Publicado: (2020)

Prognostic impact of mutation profiling in patients with stage II and III colon cancer
por: Shen, Yinchen, et al.
Publicado: (2016)

Real de-escalation or escalation in disguise?
por: Banys-Paluchowski, Maggie, et al.
Publicado: (2023)

Definitive radiotherapy dose escalation with chemotherapy for treating non-metastatic oesophageal cancer
por: Fan, Chao-Yueh, et al.
Publicado: (2018)

De-escalation of adjuvant chemotherapy for HER2 negative breast cancer
por: Okines, Dr Alicia FC, et al.
Publicado: (2021)

Is radiotherapy after primary chemotherapy (RAPCHEM) on the right path to de-escalation?
por: Socha, Joanna, et al.
Publicado: (2023)

Effectiveness of Adjuvant Chemotherapy with 5-FU/Leucovorin and Prognosis in Stage II Colon Cancer
por: Jee, Sun Hee, et al.
Publicado: (2011)

Effect of Adjuvant Chemotherapy on Stage II Colon Cancer: Analysis of Korean National Data
por: Kim, Min Ki, et al.
Publicado: (2018)

Involvement in Chemotherapy Decision Making among Patients with Stage II and III Colon Cancer
por: Austin, Jessica D., et al.
Publicado: (2023)

De-escalating axillary surgery in early-stage breast cancer()
por: Hersh, Eliza H., et al.
Publicado: (2021)

Cost‐effectiveness of adjuvant chemotherapy for high‐risk stage II and stage III colon cancer in South Africa
por: Tan, Sarah Xinhui, et al.
Publicado: (2023)

High Expression of CUL9 Is Prognostic and Predictive for Adjuvant Chemotherapy in High-Risk Stage II and Stage III Colon Cancer
por: Zheng, Peng, et al.
Publicado: (2022)

Dose-escalation by hypofractionated simultaneous integrated boost IMRT in unresectable stage III non-small-cell lung cancer
por: Zhang, Qin, et al.
Publicado: (2022)

Association of collagen deep learning classifier with prognosis and chemotherapy benefits in stage II‐III colon cancer
por: Jiang, Wei, et al.
Publicado: (2023)

A chemoresistance lncRNA signature for recurrence risk stratification of colon cancer patients with chemotherapy
por: Wang, Hao, et al.
Publicado: (2021)

Adjuvant chemotherapy does not provide survival benefits to elderly patients with stage II colon cancer
por: Lee, Kil-yong, et al.
Publicado: (2019)

Real-world evidence on adjuvant chemotherapy in older adults with stage II/III colon cancer
por: Batra, Atul, et al.
Publicado: (2020)

Effectiveness of oral fluoropyrimidine monotherapy as adjuvant chemotherapy for high-risk stage II colon cancer
por: Cho, Jung Rae, et al.
Publicado: (2022)

Erratum to “Involvement in Chemotherapy Decision Making among Patients with Stage II and III Colon Cancer”
Publicado: (2023)

Seminoma and dysgerminoma: evidence for alignment of clinical trials and de-escalation of systemic chemotherapy
por: Wood, Georgina E., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_b31bjm9i63bus4qh1mebldd2ri